Hjem › Blodkreft › Minnesota › Minneapolis
Kliniske studier for Blodkreft i Minneapolis, MN
11 studier for Blodkreft søker deltakere på steder i og rundt Minneapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruttererObservasjonsstudie
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Minneapolis VA Medical Center, Minneapolis
- og 1 flere
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi unna
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruttererFase 3
- University of Minnesota, Minneapolis
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
RekruttererFase 2
- University of Minnesota, Minneapolis
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Rekrutterer
- Masonic Cancer Center, University of Minnesota, Minneapolis
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
RekruttererFase 2
- University of Minnesota Masonic Cancer Center, Minneapolis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- University of Minnesota, Minneapolis
CIBMTR Research Database
RekruttererObservasjonsstudie
- Center for International Blood and Marrow Transplant Research, Minneapolis
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RekruttererFase 1/2
- University of Minnesota, Minneapolis
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RekruttererFase 1
- University of Minnesota, Minneapolis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Children's Hospital and Clinics of Minnesota, Minneapolis
Blodkreft-studier i andre byer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Washington, DC19 studier
- Seattle, WA18 studier
- Baltimore, MD18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Columbus, OH13 studier
- Edison, NJ13 studier
Andre studier i Minneapolis
- Ikke-småcellet lungekreft27 studier
- Brystkreft27 studier
- Eggstokkreft24 studier
- Prostatakreft23 studier
- Kreft (alle typer)22 studier
- Hjertesvikt21 studier
- Akut myelogen leukemi20 studier
- Lungekreft20 studier
- Kolorektal kreft19 studier
- Endometriekreft18 studier
- Parkinsons sykdom17 studier
- Kardiovaskulær sykdom15 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.